IBDEI0LK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9701,1,4,0)
 ;;=4^N89.0
 ;;^UTILITY(U,$J,358.3,9701,2)
 ;;=^5015885
 ;;^UTILITY(U,$J,358.3,9702,0)
 ;;=N89.3^^39^417^115
 ;;^UTILITY(U,$J,358.3,9702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9702,1,3,0)
 ;;=3^Vaginal Dysplasia,Unspec
 ;;^UTILITY(U,$J,358.3,9702,1,4,0)
 ;;=4^N89.3
 ;;^UTILITY(U,$J,358.3,9702,2)
 ;;=^5015887
 ;;^UTILITY(U,$J,358.3,9703,0)
 ;;=N90.4^^39^417^65
 ;;^UTILITY(U,$J,358.3,9703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9703,1,3,0)
 ;;=3^Leukoplakia of Vulva
 ;;^UTILITY(U,$J,358.3,9703,1,4,0)
 ;;=4^N90.4
 ;;^UTILITY(U,$J,358.3,9703,2)
 ;;=^5015894
 ;;^UTILITY(U,$J,358.3,9704,0)
 ;;=N94.2^^39^417^116
 ;;^UTILITY(U,$J,358.3,9704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9704,1,3,0)
 ;;=3^Vaginismus
 ;;^UTILITY(U,$J,358.3,9704,1,4,0)
 ;;=4^N94.2
 ;;^UTILITY(U,$J,358.3,9704,2)
 ;;=^5015918
 ;;^UTILITY(U,$J,358.3,9705,0)
 ;;=N94.0^^39^417^70
 ;;^UTILITY(U,$J,358.3,9705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9705,1,3,0)
 ;;=3^Mittelschmerz
 ;;^UTILITY(U,$J,358.3,9705,1,4,0)
 ;;=4^N94.0
 ;;^UTILITY(U,$J,358.3,9705,2)
 ;;=^265259
 ;;^UTILITY(U,$J,358.3,9706,0)
 ;;=N94.6^^39^417^30
 ;;^UTILITY(U,$J,358.3,9706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9706,1,3,0)
 ;;=3^Dysmenorrhea,Unspec
 ;;^UTILITY(U,$J,358.3,9706,1,4,0)
 ;;=4^N94.6
 ;;^UTILITY(U,$J,358.3,9706,2)
 ;;=^5015922
 ;;^UTILITY(U,$J,358.3,9707,0)
 ;;=N94.5^^39^417^29
 ;;^UTILITY(U,$J,358.3,9707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9707,1,3,0)
 ;;=3^Dysmenorrhea,Secondary
 ;;^UTILITY(U,$J,358.3,9707,1,4,0)
 ;;=4^N94.5
 ;;^UTILITY(U,$J,358.3,9707,2)
 ;;=^5015921
 ;;^UTILITY(U,$J,358.3,9708,0)
 ;;=N94.4^^39^417^28
 ;;^UTILITY(U,$J,358.3,9708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9708,1,3,0)
 ;;=3^Dysmenorrhea,Primary
 ;;^UTILITY(U,$J,358.3,9708,1,4,0)
 ;;=4^N94.4
 ;;^UTILITY(U,$J,358.3,9708,2)
 ;;=^5015920
 ;;^UTILITY(U,$J,358.3,9709,0)
 ;;=N94.3^^39^417^95
 ;;^UTILITY(U,$J,358.3,9709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9709,1,3,0)
 ;;=3^Premenstrual Tension Syndrome
 ;;^UTILITY(U,$J,358.3,9709,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,9709,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,9710,0)
 ;;=N91.0^^39^417^9
 ;;^UTILITY(U,$J,358.3,9710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9710,1,3,0)
 ;;=3^Amenorrhea,Primary
 ;;^UTILITY(U,$J,358.3,9710,1,4,0)
 ;;=4^N91.0
 ;;^UTILITY(U,$J,358.3,9710,2)
 ;;=^5015902
 ;;^UTILITY(U,$J,358.3,9711,0)
 ;;=N91.1^^39^417^10
 ;;^UTILITY(U,$J,358.3,9711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9711,1,3,0)
 ;;=3^Amenorrhea,Secondary
 ;;^UTILITY(U,$J,358.3,9711,1,4,0)
 ;;=4^N91.1
 ;;^UTILITY(U,$J,358.3,9711,2)
 ;;=^5015903
 ;;^UTILITY(U,$J,358.3,9712,0)
 ;;=N91.2^^39^417^11
 ;;^UTILITY(U,$J,358.3,9712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9712,1,3,0)
 ;;=3^Amenorrhea,Unspec
 ;;^UTILITY(U,$J,358.3,9712,1,4,0)
 ;;=4^N91.2
 ;;^UTILITY(U,$J,358.3,9712,2)
 ;;=^5015904
 ;;^UTILITY(U,$J,358.3,9713,0)
 ;;=N91.3^^39^417^73
 ;;^UTILITY(U,$J,358.3,9713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9713,1,3,0)
 ;;=3^Oligomenorrhea,Primary
 ;;^UTILITY(U,$J,358.3,9713,1,4,0)
 ;;=4^N91.3
 ;;^UTILITY(U,$J,358.3,9713,2)
 ;;=^5015905
 ;;^UTILITY(U,$J,358.3,9714,0)
 ;;=N91.4^^39^417^74
 ;;^UTILITY(U,$J,358.3,9714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9714,1,3,0)
 ;;=3^Oligomenorrhea,Secondary
 ;;^UTILITY(U,$J,358.3,9714,1,4,0)
 ;;=4^N91.4
